Cargando…
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
SIMPLE SUMMARY: Cyclophilins, a family of proteins with peptidyl prolyl isomerase activity, have been found to be overexpressed in several cancers, including hepatocellular carcinoma (HCC), and their expression is correlated to a poor prognosis. Cyclophilins play an important role in proliferation a...
Autores principales: | Simón Serrano, Sonia, Tavecchio, Michele, Grönberg, Alvar, Sime, Wondossen, Jemaà, Mohamed, Moss, Steven, Gregory, Matthew Alan, Gallay, Philippe, Elmér, Eskil, Hansson, Magnus Joakim, Massoumi, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234462/ https://www.ncbi.nlm.nih.gov/pubmed/34207224 http://dx.doi.org/10.3390/cancers13123041 |
Ejemplares similares
-
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
por: Simón Serrano, Sonia, et al.
Publicado: (2022) -
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
por: Kuo, Joseph, et al.
Publicado: (2019) -
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
por: Simón Serrano, Sonia, et al.
Publicado: (2019) -
Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma
por: Simon Serrano, Sonia, et al.
Publicado: (2020) -
Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection
por: Hansson, Magnus Joakim, et al.
Publicado: (2015)